Access to Sterile Syringes and Public Health Costs in New Jersey: Suggestions for Public Policy

Donald M. Scarry, J.D., Ph.D.

This report highlights the connections between New Jersey's restrictive distribution scheme for sterile syringes and the incidence of HIV/AIDS and Hepatitis C among injection drug users. The recommendation we offer in this report is simple and straightforward: Any steps New Jersey can take to increase access to sterile syringes should be immediately incorporated into a strong, aggressive public health strategy to combat injection drug use.

Commissioned by the Drug Policy Alliance
Harm Reduction
Syringe Access
New Jersey